| GENERIC NAME | This data is not available for free |
| INDICATION'S |
- Crohns Disease - Psoriasis - RA |
| MANUFACTURING | This data is not available for free |
| MECHANISM OF ACTION | PEGylated Fragment Humanized Anti-TNF-Alpha MAb |
| STATUS |
- Approved - US Patent Expiration: 06.06.2021 |
| UPDATE | 12.22.10 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |